Stockscreener 앱 받기
10.17
0.54%
0.055
시간 외 거래:
10.17
전일 마감가:
$10.12
열려 있는:
$10.17
하루 거래량:
120
Relative Volume:
0.03
시가총액:
$566.47M
수익:
-
순이익/손실:
-
주가수익비율:
-5.381
EPS:
-1.89
순현금흐름:
-
1주 성능:
+0.30%
1개월 성능:
-0.29%
6개월 성능:
-80.44%
1년 성능:
-80.44%
1일 변동 폭
$10.17
$10.17
1주일 범위
$10.09
$10.40
52주 변동 폭
$10.07
$10.45
Churchill Capital Corp Xi Stock (CCXI) Company Profile
Compare CCXI vs LION, XXI, UMAC, DMII, BCSS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CCXI
Churchill Capital Corp Xi
|
10.17 | 563.41M | 0 | 0 | 0 | 0.00 |
|
LION
Lionsgate Studios Corp
|
9.53 | 2.75B | 2.80B | -224.60M | -1.10M | -0.8751 |
|
XXI
Twenty One Capital Inc
|
7.07 | 2.43B | 0 | 4.35M | 456.40K | 0.3397 |
|
UMAC
Unusual Machines Inc
|
18.60 | 782.08M | 11.20M | -19.19M | -23.24M | -0.7527 |
|
DMII
Drugs Made In America Acquisition Ii Corp
|
9.96 | 653.13M | 0 | 0 | 0 | -0.0028 |
|
BCSS
Bain Capital Gss Investment Corp
|
10.12 | 591.88M | 0 | 0 | 0 | -0.0013 |
Churchill Capital Corp Xi Stock (CCXI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-10-11 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2021-10-11 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2021-10-08 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-10-08 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2021-07-07 | 업그레이드 | Stifel | Hold → Buy |
| 2021-05-07 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2021-05-07 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-05-07 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2021-05-07 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2021-05-07 | 다운그레이드 | Stifel | Buy → Hold |
| 2021-03-02 | 재확인 | H.C. Wainwright | Buy |
| 2021-03-02 | 개시 | Stifel | Buy |
| 2020-10-29 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-06-17 | 개시 | BTIG Research | Buy |
| 2020-05-27 | 개시 | Wells Fargo | Overweight |
| 2020-05-12 | 재확인 | H.C. Wainwright | Buy |
| 2020-01-24 | 재확인 | H.C. Wainwright | Buy |
| 2019-11-26 | 재확인 | H.C. Wainwright | Buy |
| 2019-11-26 | 재확인 | Piper Jaffray | Overweight |
| 2019-03-27 | 업그레이드 | B. Riley FBR | Neutral → Buy |
| 2019-02-11 | 개시 | Piper Jaffray | Overweight |
| 2018-09-07 | 개시 | B. Riley FBR | Neutral |
| 2018-08-14 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2018-06-28 | 개시 | Raymond James | Strong Buy |
| 2018-05-02 | 개시 | H.C. Wainwright | Buy |
| 2017-02-21 | 개시 | JMP Securities | Mkt Outperform |
| 2015-05-18 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2013-05-20 | 재확인 | Stifel | Buy |
| 2012-11-14 | 개시 | Stifel Nicolaus | Buy |
모두보기
Churchill Capital Corp Xi 주식(CCXI)의 최신 뉴스
Churchill Sponsor Xi Llc Net Worth (2026) - GuruFocus
Churchill Capital Corp XI Files Form 8-K Announcing Director Appointment and Company Details - Minichart
Paul Lapping and Stephen Murphy join Churchill board; Lapping named Audit Committee chair - TradingView
Free float of Churchill Capital Corp XI – NASDAQ:CCXIW - TradingView
CCXI Price History for Churchill Capital Corp Xi Cl A Stock - Barchart
Art Technology Acquisition Corp.: Performance & Quotes, ARTC Stock Price on Nasdaq Exchange - marketscreener.com
SPACSphere Acquisition Corp.: Performance & Quotes, SSAC Stock Price on Nasdaq Exchange - marketscreener.com
Soren Acquisition Corp.: Performance & Quotes, SORN Stock Price on Nasdaq Exchange - marketscreener.com
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
CMII|Columbus Circle Capital II Units|Price:9.950|Chg%:0.10 - TradingKey
CCXI Technical Analysis & Stock Price Forecast - Intellectia AI
MML Acquisition Stock (MML.H)Quote Toronto S.E. - marketscreener.com
MML Acquisition: Dividend historical data and projections - marketscreener.com
White Pearl Acquisition Corp.: Performance & Quotes, WPAC Stock Price on Nyse Exchange - marketscreener.com
Eagle Nuclear Energy Corp.: Dividend historical data and projections - marketscreener.com
Eagle Nuclear Energy Corp.: Shareholders Board Members Managers and Company Profile | US2697101093 - marketscreener.com
Eagle Nuclear Energy Corp.: Performance & Quotes, NUCL Stock Price on Nasdaq Exchange - marketscreener.com
Mountain Lake Acquisition Corp.: Dividend historical data and projections - marketscreener.com
Lake Superior Acquisition Corp.: Dividend historical data and projections - marketscreener.com
Free float of Churchill Capital Corp XI – BOATS:CCXIW - TradingView
MML Acquisition Corp.: Dividend historical data and projections - marketscreener.com
Churchill Capital Corp XIUnits (NQ: CCXIU - The Chronicle-Journal
Trailblazer Holdings, Inc.: Dividend historical data and projections - marketscreener.com
Magnetar Financial LLC Acquires 2,700,000 Shares in Churchill Ca - GuruFocus
DermTech Stock (DMTK)Quote OTC Markets - marketscreener.com
Quantum Computing Stocks: Infleqtion Pops In First Day As Public Company - Investor's Business Daily
CCXIW Stock Price, News & Analysis - Stock Titan
Churchill Capital Corp XI(NasdaqGM: CCXI) added to NASDAQ Composite Index - marketscreener.com
symbol__ Stock Quote Price and Forecast - CNN
Churchill Capital’s 47% plunge validates InvestingPro’s overvaluation alert By Investing.com - Investing.com Australia
Churchill Capital Corp XI Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing February 9, 2026 - The Manila Times
Churchill Capital Corp XI Announces Separate Trading of Shares and Warrants - TradingView
US FDA Review Team Split On Amgen’s Tavneos Years Before Withdrawal Request - Citeline News & Insights
Asking Amgen to withdraw Tavneos, FDA revisits years-old data issue - BioCentury
Amgen thumbs-down on FDA’s ask, Tavneos sales continue - BioWorld MedTech
Amgen resists FDA request to pull rare disease drug Tavneos from the market - Fierce Pharma
Amgen’s Revenue Gains Outweigh News That FDA Wants Tavneos Pulled From Market - Citeline News & Insights
Amgen Defends Tavneos Benefit-Risk Profile Following FDA Withdrawal Request - Medical Professionals Reference
US FDA Wants Tavneos Pulled From Market, Amgen Declines - Citeline News & Insights
EMA reviewing Amgen’s vasculitis drug over trial ‘data integrity’ - BioWorld MedTech
Horizon (HRZN) and Monroe Capital (MRCC) outline proxy drive for proposed merger and asset sale - Stock Titan
1 km lidar partnership for safer cars, trains and transport systems - Stock Titan
Rough Price Target for a Promising Quantum Computing Name Working With Nvidia - TheStreet Pro
CCCXChurchill Cap Corp X Latest Stock News & Market Updates - Stock Titan
Churchill Capital Corp X (CCCX) Stock News on Dec. 24, 2025: Infleqtion Quantum SPAC Deal, Latest Catalysts, and What Comes Next - TechStock²
Churchill Capital Corp XI completes $414 million IPO and private placement - Investing.com
Infleqtion Chief Scientist for Quantum Information Dr. Mark Saffman Awarded the John Stewart Bell Prize - 01net
White & Case advises the sole bookrunning manager on Churchill Capital Corp XI’s US$414 million upsized IPO - White & Case
New public company raises $414M now to buy other businesses later - Stock Titan
Churchill Capital Corp XI Announces the Pricing of Upsized $360 Million Initial Public Offering - Yahoo Finance
Another SPAC Boom is Coming; And It’s Stronger than Ever - themiddlemarket.com
Churchill Capital Corp Xi (CCXI) 재무 분석
Churchill Capital Corp Xi (CCXI)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.27%
0.29%
자본화:
|
볼륨(24시간):